AcquisitionOther
Sanofi acquired Dynavax Technologies Corporation
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Sanofi -> Dynavax Technologies Corporation · $2.2 billion
To augment presence in adult immunization by adding marketed adult hepatitis B vaccine and differentiated shingles vaccine candidate.
Open source record (SEC) ↗